Roche
Search results
Novartis Malaysia. At Novartis, we are reimagining medicine. About Novartis Malaysia. We invite you to learn more about Novartis and our impact on patients, families and their communities. Learn More. Healthcare Professionals.
Novartis in Malaysia. Novartis has a long heritage and legacy in Malaysia. Established in 1971, we are a leading multinational company employing close to 600 associates who work in the Novartis International division and Novartis Corporate Center, Kuala Lumpur.
Novartis in Malaysia. Leadership. The ability to attract, grow and keep talented people is vital for us to execute our strategy and keep developing innovative products that produce better results for patients. People and Culture.
Novartis Malaysia | 2,734 pengikut di LinkedIn. Reimagining healthcare: Making evidence-led decisions to offer value-based care for patients. | We strive to change the practice of medicine. To...
Novartis Malaysia, Petaling Jaya, Malaysia. 22,505 likes. Novartis uses science-based innovation to address some of society’s most challenging healthcare...
Explore the Novartis strategy to build a focused medicines company powered by advanced therapies and data science.
Jul 13, 2022 · PETALING JAYA: Pharmaceutical firm Novartis Malaysia has set up a hybrid office in Plaza Imazium, Damansara Uptown, as part of its strategic growth strategy and commitment to future-proof its business.
May 31, 2024 · Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease.
Jul 8, 2022 · Petaling Jaya, July 8, 2022 – Novartis Malaysia, a leading medicines company continues to solidify its presence in the market with the reveal of a new state-of-the-art office in Plaza Imazium, Damansara Uptown.
KUALA LUMPUR: Novartis Malaysia Sdn Bhd continues its commitment to keeping Malaysian frontliners and at-risk communities safe during the Covid-19 pandemic by ensuring access of treatments to patients across critical therapeutic areas.
